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The interaction of phosphatidylserine with intact smooth muscle caldesmon and caldesmon fragments obtained by bacterial expression was 
investigated by means of light scattering. Among these fra~ents only those derived from the C-terminal part of caldesmon (so-called domain 4) 
were able to interact with phospholipids. Fragments 606C (residues 606756), H7 (566710) and H2 (626710) form tight complexes with phosphat- 
idylserine, whereas fragments H8 (658-737), H9 (669-737) and fragment H4 (566-624) interact with phospholipids less effectively. It is concluded 
that the phospholipid-binding site is located in the sequence 626-710 of caldesmon. This sequence contains calmodul~n-binding sites and serine 
residues phosphorylated by protein kinase C and pro-directed protein kinases. This could explain the effects of calmodulin and phosphorylation on 
the caldesmon-phospholipid nteraction described earlier. 
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1. Introductiou 2. Materials and methis 
Caldesmon is a multifunctional protein involved in the 
regulation of smooth muscle contraction [1,2] and organ- 
ization of the cytoskeleton [3,4]. Caldesmon interacts 
with actin, tropomyosin and myosin, and many cal- 
desmon properties are regulated by ~almodulin and 
some other Ca-binding proteins f1,2,5]. In certain cell 
types caldesmon is located in the vicinity of the cell mem- 
brane [4,6] and seems to be involved in receptor capping 
[7] and exocytosis 183. These facts may be indicative of 
the binding of caldesmon to biomembranes. Indeed, re- 
cently we have shown that caldesmon interacts with 
phospholipids and that this interaction depends on cal- 
modulin and is regulated by phosphorylation [9,10]. 
Czurylo et al. [ 111 confirmed these data and in agreement 
with our results found that caldesmon preferentially in- 
teracts with acidic phospholipids. These properties of 
caldesmon are similar to those of a number of other 
actin-binding proteins (such as gelsolin, vilin, destrin, 
cofilin, profilin etc.) which also interact with phopholip- 
ids [12]. The present paper deals with the localization of 
phospholipid-binding sites of caldesmon. 
Duck gizzard caldesmon and bovine brain calmodulin were isolated 
as described earlier [13,14]. Fragments of chicken gizzard caldesmon 
were obtained by bacterial expression in the pMW172 plasmi~BL21 
(DE3) cell system described by Redwood and Marston [15]. The follow- 
ing mutants were used in the present investigation: N128 (amino acid 
residues l-128), central helix (230-419) and 606C (606-756) (number- 
ing corresponds to the chicken caldesmon sequence published by Bryan 
et al. [16]). Human caldesmon fragments were obtained as described in 
[17,18]. The following mutants were used in this investigation (number- 
ing corresponds to the chicken gizzard caldesmon sequence): H2 (resi- 
dues 626710), H3 (476510), H4 (566624), H6 (476569), H7 (566 
710), H8 (658-737) and H9 (669-737). The purity of all proteins was 
checked by SDS gel electrophoresis [19] and their concentration was 
determined by using fluorescamine [20]. We used this approach because 
both the Lowry and the Bradford methods depend on the amino acid 
composition and the length of peptides and therefore are not completely 
applicable for determination of peptide concentration. Knowing the 
amino acid composition and determining the total quantity of amino 
groups we were able to estimate the real concentration of peptides. 
Amino groups of peptides were modified by fluorescamine in 40 mM 
sodium borate buffer @H 9.1) containing 1% SDS, and the fluorescence 
of the adducts formed was excited at 390 nm and measured at 475 nm. 
Phospholipids (azolectin (Serva) and phosphatidylserine (bovine 
brain extract type 5; Sigma) were suspended in 20 mM imidazole-HCI, 
pH 7.0, containing 0.1 mM EDTA and sonicated on ice under argon 
3-5 times (30 s each) with 1 min intervals between sonications in a 
USDN-A ultrasonic disintegrator (Ukraine) working at maximum out- 
put. Phospholipids were diluted with the 20 mM imidazole-HCl, pH 
7.0, up to 0.03 mglml (or 40 PM taking the average molecular weight 
of phospholipids as being equal to 750). Light scattering at the right 
angle was measured in a 1 ml quartz cell at 27°C on a Hitachi F-3000 
fluorometer setting the wavelength of excitation and emission at 340 
nm. Suspension of phospholipids was titrated by caldesmon or cal- 
desmon fragments (tinal volume of addition was less than 50 ml). The 
values obtained were corrected for dilution and initial buffer scattering. 
Plotting $@ against weight ratio protei~phospholipid and making 
correction for the scattering induced by unbound protein [21] we deter- 
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mined the dependence of the relative molecular weights of the com- 
plexes formed on the total concentration of protein added. Assuming 
this dependence is hyperbolic and using a non-linear regression fit we 
determined the number of phospholipid molecules involved in cal- 
desmon binding and the con~ntration of protein (C,.J inducing a 
half-maximal increase in relative molecular weight. All experiments 
with calmodulin were performed in the same buffer in the presence of 
0.1 mM CaCl,. A 24-fold molar excess of calmodulin was added at the 
end of the titration. 
3. Results 
A number of different methods have been used for 
investigation of caldesmon-phospholipid interaction [9- 
1 11. The methods of gel-filtration, ultracentrifugation 
and native gel-electrophoresis [9, lo] are only semiquanti- 
tative and require rather large quantities of peptides. The 
method of intrinsic fluorescence used by Czurylo et al. 
[l l] depends on the presence of Trp residues in peptide 
and therefore is not universal. We chose the sensitive and 
quantitative method of light scattering which was earlier 
successfully used for the investigation of protein-phos- 
pholipid interaction [21,22] 
As reported earlier [9,10] titration of azolectin or 
phosphatidylserine with intact caldesmon results in a 
sharp increase in the light scattering and the half-maxi- 
mal increase of the relative molecular weight is observed 
at a caldesmon concentration equal to 0.345 PM (see 
Fig. 1 and Table 1). These values agree well with our 
earlier published results [lo]. Using the method of 
Nelsestuen and Lim [Zl] we determined the concentra- 
tions of free and bound caldesmon and constructed a 
double reciprocal plot of caldesmon-phospholipid bind- 
ing. This plot shows considerable downward curvature 
indicating the complex nature of caldesmon-phospho- 
lipid interaction. 
We analyzed the dependence of caldesmon-phospho- 
lipid interaction on the ionic strength. Increase of the 
ionic strength up to 150 mM NaCl diminished cal- 
desmon-induced light scattering by 7040%. This agrees 
well with earlier published data [lO,l 11. We found that 
although caldesmon-phospholipid binding strongly de- 
pends on ionic strength it cannot be completely reversed 
by increasing NaCl concentration up to 0.3 M. We were 
also unable to reverse ~aldesmon-phospholipid binding 
by addition of a 2-4 molar excess of calmodulin over 
caldesmon. This can mean that the interaction of cal- 
desmon with phospholipids is not completely reversible 
and that after an initial binding determined by electro- 
static interactions, caldesmon induced irreversible 
changes in the light scattering. A similar mechanism of 
interaction has been postulated for a number of phos- 
pholipid-binding proteins [22]. 
In order to localize the phospholipid-binding site of 
caldesmon, we titrated the suspension of phosphatidyl- 
serine with three large fragments derived from the N- 
terminal (N128), central (central helix, residues 230419) 
and C-terminal parts (606C) of chicken gizzard cal- 
desmon. N-terminal and central fragments of chicken 
gizzard caldesmon do not affect the light scattering of 
phospholipids, whereas the C-terminal fragment induced 
a large increase in light scattering (Table 1, Fig. 1). We 
were unable to reach saturation when titrating phospho- 
lipids with 606C because addition of large quantities of 
peptide induced a time dependent decrease of the light 
scattering, probably caused by aggregation. The data 
presented indicate that the phospholipid-binding site is 
located in the C-terminal part of caldesmon. 
Table 1 
Parameters of interaction of intact caldesmon and its fragments with phosphatidylserine (PS) 
Expressed protein Amino acid numbers Amino acid numbers 
(gizzard sequence [16]) (human sequence [29]) 
Caldesmon l-756 l-793 
Chicken caldesmon 
fragments 
N12g 1-128 
Central helix 230419 
606C 606756 
Human caldesmon 
fragments 
HZ 626710 683-767 
H3 476-510 506-566 
H4 566624 622-68 1 
H6 476-569 506625 
H7 56&710 622-767 
H8 658-737 715-793 
H9 669-737 726793 
Molecular weight Maximal RF0 Mol PS per mol C,, 
(kDa) protein 0 
87 4.04 120 0.4 
15.5 1.05 ND ND 
22.1 1.03 ND ND 
16 >1.9 >50 ND 
9 1.3 90 0.3 
7 1.9 25 12.9 
6.7 1.5 40 1.3 
14.7 1.06 ND ND 
15.6 1.4 100 0.3 
8.5 1.3 90 0.5 
7.3 1.4 60 0.6 
ND, not determined. 
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Fig. 1. Effect of intact duck gizzard caldesmon (CDj, fragments 606C, H2, H3, H4, and fragments H6, H7, H8 and H9 on the light scattering of 
a suspension of phosphatidylserine. 0 03 mg/ml of phosphatidylserine in 20 mM imidazole-HCI, pH 7.0, was titrated by caldesmon or caldesmon 
fragments and the relative molecular weight of the complexes formed which is equal to a was plotted against total protein concentration. 
We verified this assumption by using a large collection 
of fragments derived from domains 3 and 4 of human 
caldesmon. A large fragment (H6, residues 476569) rep- 
resenting domain 3 as well as a short peptide H3 (resi- 
dues 476510) located on the N-terminal end of domain 
3 (Fig. 2) induced only a small increase in the light scat- 
tering, and this increase was observed at rather high 
peptide concentration (Fig. 1, Table 1). This means that 
domain 3 does not contain the phospholipid-binding site. 
Three large peptides derived from domain 4 of cal- 
desmon induced a large increase in the light scattering. 
In addition to the above mentioned fragment 606C (res- 
idues 606-756) peptides H7 (566710) and H2 (626710) 
also effectively interacted with phosphatidylserine (Fig. 
1, Table 1). This fact completely agrees with our assump- 
tion that the phospholipid-binding site is located in do- 
main 4 of caldesmon. Splitting of domain 4 affects the 
ability of peptides to interact with phosphatidylserine. 
The fragment H4 (566624) containing the N-terminal 
part of domain 4 had low affinity for phospholipids. H8 
(658-737) and H9 (669-737) representing the C-terminal 
part of domain 4 interacted with phospholipids less effec- 
tively than 606C, H7 or H2 (Table 1, Fig. 1). Summing 
up we may conclude that domain 4 of caldesmon con- 
tains the phospholipid-binding site which is located be- 
tween residues 626 and 710. 
4. Discussion 
Our preliminary attempts to locate the phospholipid- 
binding site by the method of ultra~ntrifugation led to 
the conclusion that the C-terminal chymotryptic peptides 
of caldesmon with M, 20, 22 and 23 kDa interact with 
azolectin [lo]. Due to the low sensitivity of the method 
used we failed to detect the interaction of short cal- 
desmon peptides with phospholipids. Analyzing the pub- 
lished data [23,24] we may suppose that the peptide with 
M, 23 kDa contains residues 581-756, that with M, 22 
kDa consists of residues 597-756 or 58 l-710 and the 
peptide with M, 20 kDa is restricted by residues 629-756. 
In other words, only peptides derived from domain 4 of 
caldesmon (Fig. 2) interacted and were cosedimented 
with azolectin [lo]. This conclusion was confirmed in the 
present investigation. Indeed the peptides derived from 
domain 1 (l-128), domain 2 (230-419) or domain 3 
(476-570) practically do not interact with phospholipids. 
At the same time peptides belonging to domain 4 of 
caldesmon (606-756 (606C), 626-710 (H2) and 566-710 
(H7) formed tight complexes with phosphatidylserine. 
The phospholipid binding properties of H7 (566-730) 
and H2 (626710) are very similar (Table 1, Fig. 1). This 
means that the residues 566-626 are not important for 
phospholipid binding. This correlates with the fact that 
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Fig. 2. Domain model of smooth muscle caldesmon (A) and locatization of some of human caldesmon fragments (B) used in the present investigation 
(the numbering corresuonds to the chicken caldesmon sequence F161 with human sequence in brackets 1291). Position of Trp residues is marked by 
%: putative p~osphol~pid-binding region is marked by ve&al &es. 
fragment H4 (566624) weakly interacted with 
phosphatidylserine (Table 1). At the same time the frag- 
ments H8 (658-737) and H9 (669-737) bind phospholip- 
ids less effectively than HZ (626-710). Therefore we may 
suppose that there are two regions providing for the 
interaction of caldesmon with phospholipids. The first 
one consists of residues 626-658 (in domain 4a) and the 
second of residues 669-710) (domain 4b [l]) (Fig. 2). At 
present we do not know whether these sites operate inde- 
pendently or form a single phospholipid-binding site. As 
already mentioned many actin-binding proteins interact 
with phospholipids [12]. The primary structure of the 
phospholipid-binding sites of gelsolin, gCap39, cofilin 
and prohlin can be represented as K(X),KXKK and 
replacement of 2 lysines individually with alanine did not 
significantly affect phospholipid-binding [25]. The first 
putative phospholipid-binding region of caldesmon con- 
tains the sequence K633(X)2K(X)zK639 which seems to be 
similar to the above mentioned consensus equence. It is 
worthwhile mentioning that Wang et al. [24] detected a 
weak sequence similarity between regions containing res- 
idues 63 l-68 1 and 699-749 of caldesmon. This sequence 
similarity may explain the presence of the second phos- 
pholipid-binding site of caldesmon. If this suggestion is 
correct, then the second putative phospholipid-binding 
region of caldesmon contains the sequence 
K70’(X)4K(X),R71’ which also resembles the consensus 
motif. These sequences also contain many Pro residues. 
The two putative phospholipid-binding regions of cal- 
desmon are located close to Trp659, Ti$j9* and Trp722. 
This explains the strong effect of phospholipids on the 
intrinsic Trp fluorescence of caldesmon [111. At least one 
of these putative sequences overlaps a proposed actin 
binding inhibitory site (LYs~~* to Trp722) [28]. 
The data in the literature indicate that under certain 
experimental conditions calmodulin and phospholipids 
may interfere with caldesmon binding [lO,ll]. Cal- 
desmon has two ca~odulin-binding sites [IS]. The first 
site (site A) is restricted to residues 658-668 and the 
second (site B) is located somewhere in the sequence 
669-710, probably between Ser687 and Lys695 [18]. Both 
these sites are located close to the putative phospholipid- 
binding sites of caldesmon. This explains why calmod- 
ulin binding may affect caldesmon-phospholipid inter- 
actions and vice versa. It is worthwhile mentioning that 
the mechanism of caldesmon-phospholipid interaction is 
rather complicated and binding of caldesmon to 
phospholipids seems to be at least partially irreversible. 
Therefore it is difficult to expect simple competition be- 
tween calmodulin and phospholipids for caldesmon 
binding. For example we were unable to reverse the light 
scattering induced by caldesmon by addition of a 2% 
fold molar excess of calmodulin over caldesmon. 
The C-terminal domain of caldesmon contains a num- 
ber of sites phospho~lated by Pro-directed protein ki- 
nases and protein kinase C 126,271. Some of these sites 
(i.e. Ser667, Ser7*‘, Thr673, Thr696 for Pro-directed protein 
kinases and Ser657, Ser686 and Ser726 for protein kinase C) 
are located in the close proximity to the putative phos- 
pholipid-binding sites of caldesmon. Phosphorylation re- 
sults in the introduction of a negative charge and by this 
means may affect the initial electrostatic interaction of 
caldesmon with phospholipids. This suggestion agrees 
with our earlier published results indicating that phos- 
180 
phorylation by protein kinase C or its Ca-phospholipid- 
inde~ndent fragments decreases the interaction of cal- 
desmon with phospholipids [lo]. 
Summing up we may conclude that the C-terminal 
domain of caldesmon contains actin-, calmodulin- and 
phosphoiipid-binding sites [ l&17,18] and is phos- 
phorylated by a number of protein kinases [26,27j. We 
plan to analyze the effects of calmodulin, actin and phos- 
phorylation on caldesmon-phospholipid interaction in 
our future investigations. 
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